Does APIXABAN Cause Febrile neutropenia? 131 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Febrile neutropenia have been filed in association with APIXABAN (ELIQUIS). This represents 0.1% of all adverse event reports for APIXABAN.
131
Reports of Febrile neutropenia with APIXABAN
0.1%
of all APIXABAN reports
11
Deaths
110
Hospitalizations
How Dangerous Is Febrile neutropenia From APIXABAN?
Of the 131 reports, 11 (8.4%) resulted in death, 110 (84.0%) required hospitalization, and 3 (2.3%) were considered life-threatening.
Is Febrile neutropenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 131 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Febrile neutropenia?
CYCLOPHOSPHAMIDE (11,318)
DOXORUBICIN (8,844)
VINCRISTINE (8,676)
RITUXIMAB (6,382)
CYTARABINE (6,142)
METHOTREXATE (6,091)
ETOPOSIDE (5,966)
CARBOPLATIN (4,888)
DEXAMETHASONE (4,382)
PREDNISONE (3,956)
Which APIXABAN Alternatives Have Lower Febrile neutropenia Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ